Authors
Latest:
Improving Drug Development for Rare Patients Post-COVIDNon-profit biotech organization Cure Rare Disease utilizes collaboration amidst COVID-19 pandemic to catalyze speed of therapeutic research.
Latest:
The Future of Precision Medicine: How Biomarkers Have Influenced Clinical Trial Designs and OutcomesPlanning a clinical trial for precision medicine is markedly more challenging than more conventional treatments, as it must consider patients' variability in genes. Join our webinar to learn how to design a successful precision medicine trial. Live: Wednesday, Oct. 14, 2020 at 11am EDT| 8am PDT| 4pm BST| 5pm CEST On demand available after airing until Oct. 14, 2021.
Latest:
Enhancing Patient Experience in Clinical Trials: Six Key Insights from Global Patient SurveysAn overview of key trends in communication, logistical preferences, and demographic influences that shape patient engagement and retention in clinical trials.
Latest:
Rebadging Gains Momentum Amidst COVIDCapacity management and stability offer value for clients, their employees and FSP vendors.
Latest:
Aligning Medical Monitoring and Data ScienceCOVID-19 creates unique challenges for medical monitors.
Latest:
The State of Data FAIRification in Clinical ResearchStudy shows more support is needed for clinical teams to ‘FAIRify’ their data.
Latest:
The Missing Link in Clinical Trial RecruitmentHelping physicians and patients discuss local trials at the point of care.
Latest:
4 Tactics to Encourage Your CRAs and Sites to Adopt Remote Site MonitoringExploring effective strategies for sponsors and CROs to ensure both their CRAs and sites are supported for high levels of site acceptance and streamlined remote monitoring.
Latest:
Initial Design Considerations for Immuno-Oncology TrialsPerspectives and insights regarding regulatory considerations when planning and conducting immunotherapy studies.
Latest:
Managing Clinical Trial AgreementsHow Clinical Research Malaysia sped up CTA turnaround using a web-based system.
Latest:
Game Changer: Transformative Decentralized Clinical Trials Emerge in Latin AmericaRegional factors impact direct-to-patient modalities and bring the benefits of DCTs to life.
Latest:
Identifying Integrated Digital Platforms Designed for a Decentralized FutureCOVID-19 forces sponsors to take new approach for assessing trial support models.
Latest:
Harnessing the Power of Scientific SurveillanceStatistical methods used via this technique in centralized monitoring.
Latest:
Five Areas That Will Define the Future of Clinical TrialsFollowing COVID-19, companies are focused on solutions offering the latest technology and most value to patients.
Latest:
Understanding Study Coordinator Work QualitySurvey from the Site Council gathered insights from its members on the quality of site coordinator work.
Latest:
Four Hundred Scientists Share Secrets to Maximizing R&D DataMaximizing the impact of data is only possible when strong fundamental data management capabilities are in place.
Latest:
Beyond Regulatory Intelligence: How an FSP PV Partner Helps Ensure Global ComplianceSupport from these partners can aid drug and medical device developers in keeping up with the evolving regulatory landscape.
Latest:
Survey Results: GCP Quality and Risks in Decentralized Clinical TrialsIdentifying and providing clarity on the GCP quality and risk concerns associated with DCT modalities.
Latest:
Recruiting Trial Workers Amidst Growing ComplexityEconomic challenges combined with increased responsibility for clinical trial workers has shifted talent recruitment.
Latest:
A View of Electronic Signature in Clinical Trial Agreements in MalaysiaA focus on the position of law for e-signatures, their benefits, and the role of Clinical Research Malaysia in educating the industry on the practicality of e-signature.
Latest:
COVID-19 and Its Impact on the Future of Clinical Trial ExecutionFindings from a Tufts study examining the effects of COVID-19 on clinical trials.
Latest:
Upping the Ante for Predicting the Success of Alzheimer Disease TreatmentsThe use of modeling and biosimulation can help predict potential outcomes and improve confidence in therapeutic candidates for Alzheimer disease.
Latest:
How AI is Changing Early Drug DevelopmentThough artificial intelligence has yet to achieve its full potential, meaningful strides are still being made across the drug discovery funnel.
Latest:
Diversity by Design: Combining Strategic Protocol Planning with Accurate Real-world DataLeveraging a “diversity by design” approach can build patient narratives and optimize protocols from the onset.
Latest:
The African Medicines Agency: Impacts on the Continent’s Clinical Trials RegulationHarmonization could turn the continent into an established site for clinical research and laboratories.
Latest:
Rare Disease Clinical Trials: Strategies Learned from Duchenne Muscular DystrophyApproaches sponsors, CROs, and investigators can take from the DMD experience.
Latest:
Strategies for Building Greater DE&I in Rare Disease TrialsOutlining new approaches and resources to help ignite progress in this area.
Latest:
Considerations for Combination Product Registrations in the US and the EUIn this eBook learn about varying categorizations and how they impact combination product registrations in the US and EU markets.
Latest:
Exploring Perspectives of Fair Market Value in Clinical Trial BudgetingAs stakeholders debate fair market value in clinical trial budgeting, a new task force works to align sponsors, CROs, and sites on transparency, sustainability, and efficiency.
